📰 Lpcn News
Page 4 - Lpcn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lpcn. Real-time updates on events, politics, business and more.
June 27, 2023
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report issued on Saturday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of LPCN stock opened at $4.76 on Friday. Lipocine has a 52-week low of $3.30 and a 52-week high of $14.53. […]
June 20, 2023
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Friday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of NASDAQ:LPCN opened at $4.85 on Friday. The firm has a market capitalization of $25.22 million, a PE ratio of […]
June 11, 2023
StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research report sent to investors on Thursday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Lipocine stock opened at $4.30 on Thursday. Lipocine has a fifty-two week low of $3.30 and a fifty-two week […]
June 3, 2023
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note released on Wednesday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 4.4 % Shares of NASDAQ:LPCN opened at $4.50 on Wednesday. The company has a market capitalization of $23.40 million, a PE ratio […]
June 2, 2023
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report issued on Wednesday. The firm set a “buy” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 6.9 % Shares of Lipocine stock opened at $4.31 on Wednesday. The firm has a market cap of $22.41 million, a P/E ratio […]
May 26, 2023
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note issued to investors on Tuesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 1.6 % LPCN opened at $5.21 on Tuesday. The stock’s fifty day simple moving average is $4.92 and its 200 […]
May 19, 2023
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report published on Monday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ LPCN opened at $3.67 on Monday. Lipocine has a fifty-two week low of $3.30 and a fifty-two week high of […]
May 11, 2023
StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note published on Sunday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of LPCN stock opened at $0.27 on Friday. Lipocine has a 12-month low of $0.23 and a 12-month high of […]
May 2, 2023
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report released on Saturday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 4.0 % NASDAQ LPCN opened at $0.27 on Friday. The stock has a market capitalization of $23.93 million, a PE ratio of -1.93 […]
April 21, 2023
Lipocine Inc. (NASDAQ:LPCN – Get Rating) was the recipient of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,160,000 shares, a drop of 7.9% from the March 15th total of 1,260,000 shares. Currently, 1.4% of the company’s stock are short sold. Based on […]